Jensen Quality Growth Equity Decided to Sell Its Stake in Zoetis (ZTS)

6 days ago 4

Soumya Eswaran

Fri, March 6, 2026 astatine 8:30 AM CST 3 min read

Jensen Investment Management, an plus absorption institution based successful the US, released its fourth-quarter capitalist missive for “Jensen Quality Growth Equity Strategy”. A transcript of the missive tin beryllium downloaded here. The S&P 500 Index continued its rally successful Q4 2025, which started successful 2022. The Jensen Quality Growth Equity Composite underperformed the Index successful the 4th quarter. The Strategy returned -0.55% (net) successful Q4 2025 Vs 2.66% for the Index. At the assemblage level, the portfolio’s comparative underperformance was mostly contributed to by the Industrials sector. The outperformance of low-quality stocks added to the comparative underperformance from a prime perspective. Market attraction successful mega-cap exertion characterizes the existent concern theme. The portfolio is well-positioned to capitalize connected maturation from AI and integer transformation, portion maintaining its durability. The steadfast prioritizes holding companies that tin make economical worth implicit aggregate cycles, focusing connected quality, currency generation, and durability for semipermanent shareholder returns. Please reappraisal the Portfolio’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Jensen Quality Growth Equity Strategy highlighted stocks similar Zoetis Inc. (NYSE:ZTS). Zoetis Inc. (NYSE:ZTS) is an carnal wellness institution focused connected carnal wellness medications, vaccines, and diagnostic products. On March 05, 2026, Zoetis Inc. (NYSE:ZTS) banal closed astatine $122.23 per share. Zoetis Inc. (NYSE:ZTS) delivered a -4.07% instrumentality successful the past month, and its shares mislaid 28.26% implicit the past 12 months. Zoetis Inc. (NYSE:ZTS) has a marketplace capitalization of astir $53.866 billion.

Jensen Quality Growth Equity Strategy stated the pursuing regarding Zoetis Inc. (NYSE:ZTS) successful its 4th fourth 2025 capitalist letter:

"During the quarter, the Quality Growth Investment Team liquidated positions successful Accenture (ACN), Amphenol (APH), and Zoetis Inc. (NYSE:ZTS) from the Portfolio.

Read Entire Article